PATIENTRICITY SPECIALTY PHARMACY X

Serial Number 87377293
Registration 6590677
700

Registration Progress

Application Filed
Mar 20, 2017
Under Examination
Mar 27, 2018
Approved for Publication
Jan 30, 2018
Published for Opposition
Jan 30, 2018
Registered
Dec 14, 2021

Basic Information

Serial Number
87377293
Registration Number
6590677
Filing Date
March 20, 2017
Registration Date
December 14, 2021
Published for Opposition
January 30, 2018
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 14, 2021
Registration
Registered
Classes
035

Rights Holder

Thrifty Drug Stores, Inc.

03
Address
Suite 200
6055 Nathan Lane North
Plymouth, MN 55442

Ownership History

Thrifty Drug Stores, Inc.

Original Applicant
03
Plymouth, MN

Thrifty Drug Stores, Inc.

Owner at Publication
03
Plymouth, MN

Thrifty Drug Stores, Inc.

Original Registrant
03
Plymouth, MN

Legal Representation

Attorney
Cynthia A. Moyer
USPTO Deadlines 0 active
All 4 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

50 events
Date Code Type Description
Jun 16, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 16, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 16, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 14, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER
Nov 12, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 11, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 10, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 10, 2021 ALIE A ASSIGNED TO LIE
Nov 10, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 8, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 7, 2021 GNRT O NON-FINAL ACTION E-MAILED
May 7, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 7, 2021 CNRT W SU - NON-FINAL ACTION - WRITTEN
Mar 31, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Mar 26, 2021 IUAF S USE AMENDMENT FILED
Mar 26, 2021 EISU I TEAS STATEMENT OF USE RECEIVED
Oct 3, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 2, 2020 EX5G S SOU EXTENSION 5 GRANTED
Oct 2, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 27, 2020 EXT5 S SOU EXTENSION 5 FILED
Sep 27, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 31, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 27, 2020 EXT4 S SOU EXTENSION 4 FILED
Mar 27, 2020 EX4G S SOU EXTENSION 4 GRANTED
Mar 27, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 28, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 26, 2019 EX3G S SOU EXTENSION 3 GRANTED
Sep 26, 2019 EXT3 S SOU EXTENSION 3 FILED
Sep 26, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 29, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 27, 2019 EX2G S SOU EXTENSION 2 GRANTED
Mar 27, 2019 EXT2 S SOU EXTENSION 2 FILED
Mar 27, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 27, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 25, 2018 EX1G S SOU EXTENSION 1 GRANTED
Sep 25, 2018 EXT1 S SOU EXTENSION 1 FILED
Sep 25, 2018 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 25, 2018 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 27, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 30, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 30, 2018 PUBO A PUBLISHED FOR OPPOSITION
Jan 10, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 17, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 14, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 13, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 13, 2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 14, 2017 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED
Jun 14, 2017 GPRA F PRIORITY ACTION E-MAILED
Jun 14, 2017 CPRA R PRIORITY ACTION WRITTEN
Jun 11, 2017 DOCK D ASSIGNED TO EXAMINER

Detailed Classifications

Class 035
First Use Anywhere: Mar 23, 2020
First Use in Commerce: Mar 23, 2020

Additional Information

Design Mark
The mark consists of The words "PATENTRICITY SPECIALTY PHARMACY" where the letter "R" in "PATIENTRICITY" extends below the rest of the letters to form the letter "X".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
035

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"RX" AND "SPECIALTY PHARMACY"